1. Involvement of 5‐HT‐BDNF signaling axis in mediating synergistic antidepressant‐like effects after combined administration of two oligosaccharide esters
   Wen Shan Yang et al, 2021, Food Science & Nutrition CrossRef
2. Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2
   Diana S. Osorio et al, 2018, Journal of Neuro-Oncology CrossRef
3. Expression of Human Epidermal Growth Factor Receptor 2 in Meningiomas
   Mazaher Ramezani et al, 2020, Indian Journal of Medical and Paediatric Oncology CrossRef
4. Therapeutic treatment with fluoxetine using the chronic unpredictable stress model induces changes in neurotransmitters and circulating miRNAs in extracellular vesicles
   M. Maetzi Estévez-Cabrera et al, 2023, Heliyon CrossRef
5. MicroRNA‐345‐5p regulates depression by targeting suppressor of cytokine signaling 1
   Yulan Liu et al, 2020, Brain and Behavior CrossRef
6. The role of MAPK signaling pathway in the Her-2-positive meningiomas
   Zhaoyin Wang et al, 2016, Oncology Reports CrossRef
7. Signaling transduction regulated by 5-hydroxytryptamine 1A receptor and orexin receptor 2 heterodimers
   Qin-Qin Wang et al, 2019, Cellular Signalling CrossRef
8. Prognostic value of ErbB2/HER2 in human meningiomas
   Magnus B. Arnli et al, 2018, PLOS ONE CrossRef
9. Human epidermal growth factor receptor 2, epidermal growth factor receptor, and c-MET overexpression and survival in biliary tract cancer
   Wei Zhou et al, 2018, Journal of Cancer Research and Therapeutics CrossRef
10. Meningioma: Signaling pathways and tumor growth
    Brian Andrew Burnett et al, 2020, Meningiomas, Part I CrossRef
11. Bupleurum chinense DC improves CUMS-induced depressive symptoms in rats through upregulation of the cAMP/PKA/CREB signalling pathway
    Baijin Chang et al, 2022, Journal of Ethnopharmacology CrossRef